Holy basil for stress and sleep: one branded-extract trial needs replication
What an eight-week holy basil trial found, how wearable and questionnaire outcomes differ and why extract matching matters.
What an eight-week holy basil trial found, how wearable and questionnaire outcomes differ and why extract matching matters.
How a small panic-disorder crossover trial compares with a later meta-analysis finding no significant anxiety benefit.
A guide to a new mushroom-blend trial, multiple comparisons, trend-level secondary findings and product-identification problems.
A guide to recent ginseng stress trials, extract differences, mixed fatigue findings and the limits of biomarker-based claims.
A guide to yeast mannan, GOS, FOS and resistant dextrin trials showing why prebiotic effects cannot be generalized.
A guide to SAMe research, broad CNS reviews, limited sleep-specific evidence, medicine interactions and mania risk.
What a 2026 vitamin D trial in deficient adults found, why no placebo matters and how high study doses differ from routine use.
Why chamomile studies and a new multi-ingredient trial do not prove isolated apigenin improves sleep, despite mechanistic marketing.
How CoQ10 fatigue trials differ from sleep studies, why combination formulas complicate attribution and what labels should disclose.
What a small 5-HTP sleep trial found, why serotonin pathways raise interaction concerns and how product claims can overreach.
A guide to hops-and-valerian insomnia trials, combination-product attribution, subjective versus objective sleep and product matching.
How current sleep guidance uses iron studies in restless legs syndrome, what trials show and why self-treatment can be risky.